BG108548A - Хетероциклични съединения и използването им като d-аланил-d-аланин лигазни инхибитори - Google Patents

Хетероциклични съединения и използването им като d-аланил-d-аланин лигазни инхибитори Download PDF

Info

Publication number
BG108548A
BG108548A BG108548A BG10854804A BG108548A BG 108548 A BG108548 A BG 108548A BG 108548 A BG108548 A BG 108548A BG 10854804 A BG10854804 A BG 10854804A BG 108548 A BG108548 A BG 108548A
Authority
BG
Bulgaria
Prior art keywords
alkyl
hydrogen
compound
aryl
nitrogen
Prior art date
Application number
BG108548A
Other languages
Bulgarian (bg)
English (en)
Inventor
Scott Moe
Paul Ala
Emanuele Perola
Carlos FAERMAN
Jacob Clement
Janid Ali
Paul Will
Salvatore Marchese
Andrew MAGEE
John GAZZANIGA
Christopher Farady
Manuel Navia
Patrick Connelly
Original Assignee
Pliva D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva D.D. filed Critical Pliva D.D.
Publication of BG108548A publication Critical patent/BG108548A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BG108548A 2001-06-28 2004-01-28 Хетероциклични съединения и използването им като d-аланил-d-аланин лигазни инхибитори BG108548A (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30168501P 2001-06-28 2001-06-28

Publications (1)

Publication Number Publication Date
BG108548A true BG108548A (bg) 2005-05-31

Family

ID=23164426

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108548A BG108548A (bg) 2001-06-28 2004-01-28 Хетероциклични съединения и използването им като d-аланил-d-аланин лигазни инхибитори

Country Status (16)

Country Link
US (3) US20030176436A1 (sh)
EP (2) EP1432713A4 (sh)
CN (2) CN1547472A (sh)
BG (1) BG108548A (sh)
BR (1) BR0211310A (sh)
CA (2) CA2451800A1 (sh)
CZ (2) CZ200442A3 (sh)
EA (1) EA200400094A1 (sh)
EE (2) EE200400042A (sh)
HU (2) HUP0700061A2 (sh)
IL (2) IL159538A0 (sh)
MX (1) MXPA04000159A (sh)
PL (2) PL374259A1 (sh)
SK (1) SK302004A3 (sh)
WO (2) WO2003002064A2 (sh)
YU (2) YU102503A (sh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0217703D0 (en) * 2002-07-31 2002-09-11 Univ Liverpool Pharmaceutical composition
WO2006050843A1 (en) * 2004-11-09 2006-05-18 F. Hoffmann-La Roche Ag Aminoquinazolines compounds
MX2008000885A (es) * 2005-07-21 2008-03-18 Hoffmann La Roche Compuestos de pirido[2,3-d]pirimidin-2,4-diamina como inhibidores de la proteina tirosina fosfatasa 1b.
GB0608822D0 (en) * 2006-05-04 2006-06-14 Chroma Therapeutics Ltd Inhibitors of DHFR
SI22338A (sl) * 2006-08-18 2008-02-29 Univerza V Ljubljani, Fakulteta Za Farmacijo Diazendikarboksamidi kot inhibitorji d-alanil-d-alanin ligaze
TW200831528A (en) 2006-11-30 2008-08-01 Astrazeneca Ab Compounds
CN101084901B (zh) * 2007-06-22 2011-12-21 复旦大学 一种葡萄球菌抑制剂
CN101983191B (zh) * 2008-02-01 2013-11-20 武田药品工业株式会社 作为hsp90抑制剂的肟衍生物
DE112010001212T5 (de) * 2009-03-20 2012-07-05 The Board Of Regents Of The University Of Texas System Verfahren, urn einem medizinischen Gerät antimikrobielle Aktivität zu verleihen
NZ597911A (en) * 2009-08-31 2014-06-27 Dow Agrosciences Llc Pteridines and their use as agrochemicals
SI3321265T1 (sl) 2015-03-04 2020-07-31 Gilead Sciences, Inc. Spojine 4,6-diamino-pirido(3,2-d)pirimidina in njihova uporaba kot modulatorji toličnih receptorjev
CN106316966A (zh) * 2015-06-15 2017-01-11 董运勤 医药中间体n-(2-吡嗪甲基)苄胺磷酸盐化合物制备方法
US10640499B2 (en) 2016-09-02 2020-05-05 Gilead Sciences, Inc. Toll like receptor modulator compounds
MA46093A (fr) 2016-09-02 2021-05-19 Gilead Sciences Inc Composés modulateurs du recepteur de type toll
KR20200012823A (ko) 2017-02-01 2020-02-05 예일 유니버시티 이뇨제 내성의 치료
EP3735421A4 (en) 2018-01-05 2021-09-22 Corvidia Therapeutics, Inc. METHOD OF TREATMENT OF IL-6 MEDIATED INFLAMMATION WITHOUT IMMUNSUPPRESSION
TW202045001A (zh) * 2019-02-01 2020-12-16 美商富曼西公司 作為除草劑的經取代吡啶類及嘧啶類化合物
TW202212339A (zh) 2019-04-17 2022-04-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI751516B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202115056A (zh) 2019-06-28 2021-04-16 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法
GB2626567A (en) * 2023-01-26 2024-07-31 De Montfort Univ Quinazoline derivatives for use as a medicament

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2949466A (en) * 1958-03-04 1960-08-16 Parke Davis & Co Pyrimidine compounds and means of producing the same
US3134778A (en) * 1963-08-20 1964-05-26 Smith Kline French Lab 2,5,7-triamino-4-phenyl (or thienyl)-pyrimido[4,5-d]pyrimidines
RO56210A2 (sh) 1970-12-28 1974-08-01
US4079056A (en) * 1975-03-31 1978-03-14 The United States Of America As Represented By The Department Of Health, Education And Welfare Method of making pteridine compounds
DE2750288A1 (de) * 1977-11-10 1979-05-17 Thomae Gmbh Dr K Neue 9-(omega-heteroarylamino- alkylamino)-erythromycine, ihre salze, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3445298A1 (de) 1984-12-12 1986-06-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue pteridine, verfahren zu ihrer herstellung und deren verwendung als zwischenprodukte oder als arzneimittel
WO1992017478A1 (en) 1991-04-08 1992-10-15 Duquesne University Of The Holy Ghost 5-ALKYL-6-[[AMINO]METHYL]PYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AND METHODS OF PREPARING AND USING THESE DERIVATIVES
US5547954A (en) * 1994-05-26 1996-08-20 Fmc Corporation 2,4-Diamino-5,6-disubstituted-and 5,6,7-trisubstituted-5-deazapteridines as insecticides
DE59610771D1 (de) * 1995-02-27 2003-11-20 Hoffmann La Roche Dioxopyrrolo-pyrrolderivate
WO1999050264A1 (fr) * 1998-03-30 1999-10-07 Kyowa Hakko Kogyo Co., Ltd. Derives de quinazoline
JP2000239277A (ja) * 1999-02-19 2000-09-05 Kyowa Hakko Kogyo Co Ltd イミダゾキナゾリン誘導体
GB0219893D0 (en) 2002-08-27 2002-10-02 Melacure Therapeutics Ab Pharmaceutically active compounds

Also Published As

Publication number Publication date
BR0211310A (pt) 2006-10-31
EP1411949A2 (en) 2004-04-28
CN1543465A (zh) 2004-11-03
HUP0700061A2 (en) 2007-05-02
WO2003002064A3 (en) 2003-10-23
CZ200443A3 (cs) 2004-08-18
YU102503A (sh) 2006-08-17
YU102303A (sh) 2006-08-17
WO2003001887A3 (en) 2003-08-21
EP1432713A4 (en) 2005-05-11
US20080090847A1 (en) 2008-04-17
US7345048B2 (en) 2008-03-18
CA2451800A1 (en) 2003-01-09
WO2003001887A2 (en) 2003-01-09
PL374259A1 (en) 2005-10-03
CA2451840A1 (en) 2003-01-09
EE200400043A (et) 2004-10-15
SK302004A3 (sk) 2005-07-01
US20030181470A1 (en) 2003-09-25
US20030176436A1 (en) 2003-09-18
CZ200442A3 (cs) 2004-10-13
WO2003002064A2 (en) 2003-01-09
CN1547472A (zh) 2004-11-17
EE200400042A (et) 2004-10-15
EP1432713A2 (en) 2004-06-30
IL159540A0 (en) 2004-06-01
EA200400094A1 (ru) 2005-08-25
MXPA04000159A (es) 2005-01-07
HUP0700040A2 (en) 2007-05-29
EP1411949A4 (en) 2004-11-24
IL159538A0 (en) 2004-06-01
PL374589A1 (en) 2005-10-31

Similar Documents

Publication Publication Date Title
US20080090847A1 (en) Heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors
US8318720B2 (en) Acrylamide derivatives as Fab I inhibitors
JP5143000B2 (ja) 抗感染症薬としての８−メトキシ−９Ｈ−イソチアゾロ［５，４−ｂ］キノリン−３，４−ジオンおよび関連化合物
RU2609259C2 (ru) Пиримидиновые ингибиторы гиразы и топоизомеразы iv
JP2016047853A (ja) 窒素含有化合物及びその使用
KR101900249B1 (ko) 자이라제 억제제 （ｒ）­１­에틸­３­［６­플루오로­５­［２­（１­하이드록시­１­메틸­에틸）피리미딘­５­일］­７­（테트라하이드로푸란­２­일）­１ｈ­벤즈이미다졸­２­일］우레아의 고체 형태
KR20160108409A (ko) 질소 내포 화합물 및 항세균제로서 이들의 용도
SG191924A1 (en) Solid forms of gyrase inhibitor (r)-1-ethyl-3-[5-[2-{1-hydroxy-1-methyl-ethyl}pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl}-1h-benzimidazol-2-yl]urea
WO2016007837A1 (en) Carbonyl linked bicyclic heteroaryl antibiotic tolerance inhibitors
US7199128B2 (en) 8-N-substituted-2H-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents
US20030166645A1 (en) Novel nitrofuran-containing heterocyclic compounds and uses thereof
AU2002324455A1 (en) Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors
Wernke Synthetic Studies of Colibactin, a Carcinogenic Gut Microbiome Metabolite
JP2004137185A (ja) チオフェン骨格を有する抗菌剤
US20130165471A1 (en) 2-substituted-thienoquinolones and related compounds as anti-infective agents
MX2008001344A (es) 8-metoxi-9h-isotiazolo[5,4-b]quinolin-3,4-dionas y compuestos relacionados como agentes anti-infecciosos
NZ612912B2 (en) Solid forms of gyrase inhibitor (r)-1-ethyl-3-[5-[2-{1-hydroxy-1-methyl-ethyl}pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl}-1h-benzimidazol-2-yl]urea